Cargando…
A New Bioassay Platform Design for the Discovery of Small Molecules with Anticancer Immunotherapeutic Activity
Immunotherapy takes advantage of the immune system to prevent, control, and eliminate neoplastic cells. The research in the field has already led to major breakthroughs to treat cancer. In this work, we describe a platform that integrates in vitro bioassays to test the immune response and direct ant...
Autores principales: | Gallo, Carmela, Barra, Giusi, Saponaro, Marisa, Manzo, Emiliano, Fioretto, Laura, Ziaco, Marcello, Nuzzo, Genoveffa, d’Ippolito, Giuliana, De Palma, Raffaele, Fontana, Angelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7760914/ https://www.ncbi.nlm.nih.gov/pubmed/33260400 http://dx.doi.org/10.3390/md18120604 |
Ejemplares similares
-
The immunoregulatory effect of the TREM2-agonist Sulfavant A in human allogeneic mixed lymphocyte reaction
por: Barra, Giusi, et al.
Publicado: (2023) -
Sulfavant A as the first synthetic TREM2 ligand discloses a homeostatic response of dendritic cells after receptor engagement
por: Gallo, Carmela, et al.
Publicado: (2022) -
Preparation, Supramolecular Aggregation and Immunological Activity of the Bona Fide Vaccine Adjuvant Sulfavant S
por: Manzo, Emiliano, et al.
Publicado: (2020) -
Diasteroselective Colloidal Self-Assembly Affects
the Immunological Response of the Molecular Adjuvant Sulfavant
por: Manzo, Emiliano, et al.
Publicado: (2019) -
Correction to “Diastereoselective Colloidal
Self-Assembly Affects the Immunological Response of the Molecular
Adjuvant Sulfavant”
por: Manzo, Emiliano, et al.
Publicado: (2019)